Read the latest KCSN newsletter and new KCSN website guide here
The first issue of the KCSN newsletter for 2017 has [...]
Under-reporting immunotherapy-related side-effects is a concern in kidney cancer
In an interview with OncLive at the 2016 Kidney Cancer [...]
Hope that vaccines may improve immunotherapy outcomes in kidney cancer
The following is a link to an interview with Dr Tian [...]
Agency warns about the cancer risk of overdone toast and roast potatoes
A British agency has launched a public-awareness campaign about the [...]
Doctors warn of cancelled cancer operations due to bed shortages
Senior doctors are concerned about the number of cancelled cancer [...]
Potential novel biomarker for kidney cancer
A novel potential biomarker for renal cell carcinoma (RCC) tumours [...]
European guidelines for the treatment of kidney cancer have been updated
The European Association of Urology (EAU) Renal Cell Carcinoma (RCC) [...]
Combination therapy is promising for kidney cancer
In recent years, drugs that target the vascular endothelial growth [...]
Leading kidney cancer specialist talks about nivolumab versus everolimus
In the following video, Dr Robert J. Motzer from Memorial Sloan [...]
Dalantercept plus axitinib combination may improve outcomes for people with advanced kidney cancer
Results from the first part of the phase 2 DART [...]
